ARCHIVES

Campath Improves PFS In B-Cell CLL In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 30 No. 1 | January 26, 2007

Download PDF Visit The Full Archive

Related Articles

ACS Chief Medical Officer Brawley Urges Audit Of I-ELCAP Lung Screening Data.

September 26, 2008

FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza

December 26, 2014

SEER Program Expansion Through Cost-Sharing.

March 23, 2001

NCI Programs: BSA Approves concept For Grants Program In Statistical Modeling

July 16, 1999

MRI Contract: AACI Group Still Seething

August 8, 1986

Regulatory Policy: Bush To Seek Legislation For Pediatric Drug Tests.

January 3, 2003